FINWIRES · TerminalLIVE
FINWIRES

美元週一早盤走強;本週市場焦點:成屋銷售、褐皮書、國際貨幣基金組織會議

-- 週一早盤,美元兌主要貿易夥伴走強,市場關注美東時間上午10:00公佈的3月成屋銷售數據以及美東時間下午6:20美聯儲理事斯蒂芬·米蘭的演講。 週二的重點數據包括小型企業信心指數和生產者物價指數。 週三的主要數據包括進出口價格數據、4月製造業數據的初步數據以及聯準會褐皮書。 週四的主要數據包括每周初請失業金人數、4月服務業初步數據以及3月工業生產數據。 週五的數據較為清淡,僅有聖路易斯聯邦儲備銀行對第一季GDP的預測值。 國際貨幣基金組織本週召開年會,因此聯準會官員和其他央行代表的發言將會頻繁。 週一外匯市場動態簡報: 歐元兌美元從週五美國收盤時的1.1729跌至1.1700,週五早盤同一時間點為1.1713。週一沒有歐元區數據公佈,但歐洲央行副行長路易斯·德·金多斯將於美國東部時間上午8:15發表演說。歐洲央行下次會議定於4月30日舉行。 英鎊兌美元從週五美國收盤時的1.3469跌至1.3439,週五早盤同一時間點為1.3440。英國3月同店銷售數據將於週一晚間美國東部時間7:01公佈。英國央行下次會議定於4月30日舉行。 美元/日圓從週五美國收盤時的159.3031升至159.6931,週五早盤同一時間點為159.2051。根據隔夜公佈的數據,日本貨幣存量在3月加速成長。日本央行下次會議定於4月27日至28日舉行。 美元兌加幣匯率從週五美國收盤時的1.3835升至1.3837,週五早盤同一時間匯率為1.3831。加拿大2月建築許可數據將於美國東部時間上午8:30公佈。加拿大央行下次會議定於4月29日舉行。

Related Articles

Asia

National Australia Bank Shares Down After Resolution of Union Court Proceedings

National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."

$ASX:NAB
Asia

Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant

Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.

$ASX:CUV
Asia

XRF Scientific Completes Acquisition of Combustion Gas Analysis Business

XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.

$ASX:XRF